MEDXT is projected to decline to $0.000148 by 2027, a -43% move from its current price of $0.0002579. MEDXT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell. Market sentiment sits at 22/100 (Extreme Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 5/26/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.0002405 | $0.0002578 | $0.0002764 | -0.01% |
| May 30 | $0.0002337 | $0.0002578 | $0.0002844 | -0.03% |
| May 31 | $0.0002285 | $0.0002578 | $0.0002907 | -0.04% |
| Jun 1 | $0.0002243 | $0.0002577 | $0.0002962 | -0.06% |
| Jun 2 | $0.0002206 | $0.0002577 | $0.000301 | -0.07% |
| Jun 3 | $0.0002173 | $0.0002577 | $0.0003055 | -0.09% |
| Jun 4 | $0.0002143 | $0.0002576 | $0.0003096 | -0.10% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0002143 | $0.0002576 | $0.0003096 | -0.10% |
| Week 2 | $0.0001984 | $0.0002573 | $0.0003338 | -0.21% |
| Week 3 | $0.000187 | $0.0002571 | $0.0003535 | -0.31% |
| Week 4 | $0.0001778 | $0.0002568 | $0.000371 | -0.41% |
| Week 5 | $0.0001701 | $0.0002566 | $0.000387 | -0.51% |
| Week 6 | $0.0001634 | $0.0002563 | $0.0004021 | -0.62% |
| Week 7 | $0.0001574 | $0.000256 | $0.0004164 | -0.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Medxt is a cybersecurity innovation company building sovereign, secure, blockchain based systems to protect the world’s most sensitive data. The project sits in the Ethereum Ecosystem category and is led by a global team of security architects, engineers, and compliance experts to eliminate the threat of ransomware and restore trust in data no matter the industry, no matter the challenge. We protect what matters most, your data.
MEDXT is currently priced at $0.0002579 with a market capitalization of $5.35M and a market rank of 1626. The current price aligns with a near-term forecast that shows a range of outcomes across the next several years, including a 2026 average of $0.0002579 and a 2026 min of $0.0002174. The long-range forecast points to higher potential in 2030 and beyond, with a 2050 average price of $0.0007083 and a forecast ROI of 174.7.
A major floor 76.7% below — a decisive break under it would weaken the trend.
The nearest floor, 15.7% below — buyers have tended to step in here.
The nearest ceiling, 83.7% above — a clean break opens room to run.
A major ceiling 122.1% above — clearing it would confirm fresh momentum.
Key MEDXT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MEDXT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0002494 | Buy | $0.000252 | Buy |
| MA 10 | $0.0002464 | Buy | $0.0002546 | Buy |
| MA 20 | $0.0002705 | Sell | $0.0002737 | Sell |
| MA 50 | $0.0003447 | Sell | $0.0003161 | Sell |
| MA 100 | $0.0003283 | Sell | $0.0004085 | Sell |
| MA 200 | $0.000649 | Sell | $0.0007413 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.27 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -32.26 | Neutral |
| Williams %R (14) | -46.17 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -11.88 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 53.83 | Neutral |
| TRIX (15) | -1.40 | Sell |
| Awesome (5,34) | -0.00 | Sell |
| Ultimate (7,14,28) | 56.67 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.00 | Sell |
| ADX (14) | 23.97 | Sell |
| ATR (14) | 0.00 | Info |
The 30-day technical picture is neutral, with RSI14 at 40. The price action is guided by SMA50 at $0.0003447 and SMA200 at $0.000649, with a defined near-term dynamic between support and resistance. The key support level is $0.0002174 and the resistance is $0.0004737, and the 30-day range spans from $0.0001762 to $0.0003773.
Volatility remains high, with annualized volatility at 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.0002174 | $0.0002579 | $0.0003557 | 0% | Neutral | |
| $0.000102 | $0.000148 | $0.0002328 | -43% | Bearish | |
| $0.0001565 | $0.0002448 | $0.0004129 | -5% | Neutral | |
| $0.0002051 | $0.0003425 | $0.0006096 | +33% | Bullish | |
| $0.0001867 | $0.0003313 | $0.0006163 | +28% | Bullish | |
| $0.0001063 | $0.0001999 | $0.0003864 | -22% | Bearish | |
| $0.00009701 | $0.0001929 | $0.0003856 | -25% | Bearish | |
| $0.0002395 | $0.0005029 | $0.001036 | +95% | Bullish | |
| $0.000164 | $0.0003637 | $0.0007701 | +41% | Bullish | |
| $0.00006679 | $0.0001484 | $0.0003223 | -42% | Bearish | |
| $0.0001376 | $0.0003059 | $0.0007035 | +19% | Neutral | |
| $0.0003187 | $0.0007083 | $0.001629 | +175% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.0002174 | $0.0002579 | $0.0003091 | +0.00% |
| June 2026 | $0.0002236 | $0.0002709 | $0.0003419 | +5.05% |
| July 2026 | $0.0002058 | $0.0002544 | $0.0003307 | -6.08% |
| August 2026 | $0.00018 | $0.0002262 | $0.0003005 | -11.12% |
| September 2026 | $0.000199 | $0.0002533 | $0.0003428 | +12.01% |
| October 2026 | $0.0002225 | $0.0002868 | $0.0003945 | +13.22% |
| November 2026 | $0.0002041 | $0.000266 | $0.0003711 | -7.24% |
| December 2026 | $0.0001911 | $0.0002517 | $0.0003557 | -5.40% |
Click any year to see its month-by-month MEDXT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, MEDXT is projected to trade between $0.0002174 and $0.0003557, averaging $0.0002579 — a potential gain of 0% from today's $0.0002579. A consolidation phase looks the most probable path here.
MEDXT's 2027 outlook centres on $0.000148, within a $0.000102 to $0.0002328 range. That is -43% versus the projected 2026 average. That marks a -43% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2028, MEDXT could reach as high as $0.0004129, with a base case around $0.0002448 and support toward $0.0001565 — roughly -5% from $0.0002579. A consolidation phase looks the most probable path here.
Expect MEDXT to range from $0.0002051 to $0.0006096 through 2029. The $0.0003425 average target implies a +33% move from current prices. That is up +40% on the projected 2028 average. Momentum favours further upside here.
The MEDXT price prediction for 2030 points to an average of $0.0003313 (low $0.0001867, high $0.0006163) — a potential gain of +28% on today's $0.0002579. Buyers look set to stay in control over this stretch.
In 2031, MEDXT is projected to trade between $0.0001063 and $0.0003864, averaging $0.0001999 — a potential decline of -22% from today's $0.0002579. That is -40% versus the projected 2030 average. A cyclical pullback looks likely — prices rarely move in a straight line.
MEDXT's 2032 outlook centres on $0.0001929, within a $0.00009701 to $0.0003856 range. That is -4% versus the projected 2031 average. That marks a -25% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2033, MEDXT could reach as high as $0.001036, with a base case around $0.0005029 and support toward $0.0002395 — roughly +95% from $0.0002579. Momentum favours further upside here.
Expect MEDXT to range from $0.000164 to $0.0007701 through 2034. The $0.0003637 average target implies a +41% move from current prices. That is -28% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
The MEDXT price prediction for 2035 points to an average of $0.0001484 (low $0.00006679, high $0.0003223) — a potential decline of -42% on today's $0.0002579. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2040, MEDXT is projected to trade between $0.0001376 and $0.0007035, averaging $0.0003059 — a potential gain of +19% from today's $0.0002579. That is up +106% on the projected 2035 average. A consolidation phase looks the most probable path here.
MEDXT's 2050 outlook centres on $0.0007083, within a $0.0003187 to $0.001629 range. That is up +132% on the projected 2040 average. That marks a +175% change versus current levels. Momentum favours further upside here.
Investing $1,000 in MEDXT today (≈ 3,877,772.607414 MEDXT) could be worth
$2,746.62
+$1,746.62 (+175%) by 2050 · US Dollar
Based on the average projected MEDXT price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MEDXTwould be worth at today's price.
$1,000 invested in MEDXT on Aug 6, 2025 (≈ 332,270.759832 MEDXT) would be worth
$85.69
-$914.31 (-91.4%) today · 0.09× · US Dollar
Based on a MEDXT entry price of $0.00301 vs. today's $0.000258.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.00023 | $1,119.42 | +11.9% |
| 1 month ago | $0.000448 | $576.19 | -42.4% |
| 3 months ago | $0.000302 | $853.92 | -14.6% |
| 6 months ago | $0.001201 | $214.7 | -78.5% |
| All time ago | $0.00301 | $85.69 | -91.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MEDXT forecast.
Our base-case forecast reaches $0.00052 around 2050.
Implied market cap at $0.00052: $10.79M
The year-by-year forecast shows a mixed path through the mid term and notable upside later. In 2026, the avg is $0.0002579 and the max is $0.0003557 with ROI 0 and sentiment NEUTRAL. In 2027 the avg drops to $0.000148 and ROI is -42.6 with a BEARISH sentiment.
In 2028 the avg is $0.0002448 and ROI -5.1 with a NEUTRAL sentiment, followed by a 2029 avg of $0.0003425 and ROI 32.8 with a BULLISH sentiment. The 2030 forecast shows an avg of $0.0003313 and ROI 28.5 with a BULLISH sentiment. The long horizon includes 2033 with avg $0.0005029 and ROI 95 (BULLISH), 2034 with avg $0.0003637 and ROI 41 (BULLISH), and 2035 with avg $0.0001484 and ROI -42.5 (BEARISH).
For the distant horizon, 2040 carries an avg of $0.0003059 and ROI 18.6 (NEUTRAL), while 2050 yields an avg of $0.0007083 and ROI 174.7 (BULLISH). These are estimates and not guarantees, and a range of outcomes across years reflects varying market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an avg of $0.0003313 with ROI 28.5 and a BULLISH sentiment.
Forecasts show a mix of years with bullish and bearish signals. Notably, 2050 forecasts an avg of $0.0007083 with ROI 174.7 and a BEARISH years such as 2027 (ROI -42.6) and 2035 (ROI -42.5). These are only estimates and carry risk.
Yes, the 2033 forecast includes a max of $0.001036 with avg $0.0005029 and ROI 95, indicating a potential above $0.001 under certain conditions.
The 30-day range is $0.0001762 to $0.0003773, with current price at $0.0002579. RSI14 is 40, SMA50 is $0.0003447, SMA200 is $0.000649, support at $0.0002174, and resistance at $0.0004737.
Current price is $0.0002579 and market cap is $5.35M, with a market rank of 1626.
MEDXT Community Discussion
0Share your MEDXT price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.